PTI - Proteostasis Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue2,8405,3418,3844,312
Cost of Revenue----
Gross Profit2,8405,3418,3844,312
Operating Expenses
Research Development47,91550,70032,45220,600
Selling General and Administrative18,10714,61413,3878,246
Non Recurring----
Others----
Total Operating Expenses66,02265,31445,83928,846
Operating Income or Loss-63,182-59,973-37,455-24,534
Income from Continuing Operations
Total Other Income/Expenses Net1,350541223-506
Earnings Before Interest and Taxes-63,182-59,973-37,455-24,534
Interest Expense----599
Income Before Tax-61,832-59,432-37,232-25,040
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-61,832-59,432-37,232-25,040
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-61,832-59,432-37,232-25,040
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-61,832-59,432-38,610-23,309